Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shengjun Xu

Showing results (111-120 of 122) with videos related to

Pageof 13
Sort By:
Biomarker Research|February 6, 2024
Transcription factor BACH1 in cancer: roles, mechanisms, and prospects for targeted therapyDian Hu, Zerui Zhang, Xiangyuan Luo, et al.
Cell Death Discovery|February 8, 2024
SOX on tumors, a comfort or a constraint?Junqing Jiang, Yufei Wang, Mengyu Sun, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|March 15, 2021
Self-Activated Cascade-Responsive Sorafenib and USP22 shRNA Co-Delivery System for Synergetic Hepatocellular Carcinoma TherapyShengjun Xu, Sunbin Ling, Qiaonan Shan, et al.
Cancer Letters|May 19, 2026
USP22 Inhibition Potentiates GPC3 Chimeric Antigen Receptor Macrophages Efficacy in Hepatocellular Carcinoma by Downregulating Tumor CD24 ExpressionJun Pan, Sheng Pan, Yunguo Lei, et al.
Journal of Translational Medicine|October 20, 2023
Insulin-induced gene 2 protects against hepatic ischemia-reperfusion injury via metabolic remodelingYichao Wu, Changbiao Li, Abid Ali Khan, et al.
Materials Today. Bio|July 12, 2026
Biomimetic interfacial water-regulated hybrid dual-layer hydrogel for wound healing, anti-adhesion and hemostasis post partial hepatectomyJun Li, Xiang Wu, Yanhua Wan, et al.
International Immunopharmacology|December 19, 2023
SRSF10 facilitates HCC growth and metastasis by suppressing CD8<sup>+</sup>T cell infiltration and targeting SRSF10 enhances anti-PD-L1 therapyXiangyuan Luo, Zerui Zhang, Siwen Li, et al.
Journal for Immunotherapy of Cancer|November 29, 2023
TP53/mTORC1-mediated bidirectional regulation of PD-L1 modulates immune evasion in hepatocellular carcinomaJiongjie Yu, Sunbin Ling, Jiachen Hong, et al.
Signal Transduction and Targeted Therapy|September 19, 2024
The p-MYH9/USP22/HIF-1α axis promotes lenvatinib resistance and cancer stemness in hepatocellular carcinomaQiaonan Shan, Lu Yin, Qifan Zhan, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 21, 2022
E2F7 promotes mammalian target of rapamycin inhibitor resistance in hepatocellular carcinoma after liver transplantationSunbin Ling, Qifan Zhan, Guangjiang Jiang, et al.
Pageof 13

Showing results (111-120 of 122) with videos related to

Sort By:
Pageof 13
Biomarker Research|February 6, 2024
Transcription factor BACH1 in cancer: roles, mechanisms, and prospects for targeted therapyDian Hu, Zerui Zhang, Xiangyuan Luo, et al.
Cell Death Discovery|February 8, 2024
SOX on tumors, a comfort or a constraint?Junqing Jiang, Yufei Wang, Mengyu Sun, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|March 15, 2021
Self-Activated Cascade-Responsive Sorafenib and USP22 shRNA Co-Delivery System for Synergetic Hepatocellular Carcinoma TherapyShengjun Xu, Sunbin Ling, Qiaonan Shan, et al.
Cancer Letters|May 19, 2026
USP22 Inhibition Potentiates GPC3 Chimeric Antigen Receptor Macrophages Efficacy in Hepatocellular Carcinoma by Downregulating Tumor CD24 ExpressionJun Pan, Sheng Pan, Yunguo Lei, et al.
Journal of Translational Medicine|October 20, 2023
Insulin-induced gene 2 protects against hepatic ischemia-reperfusion injury via metabolic remodelingYichao Wu, Changbiao Li, Abid Ali Khan, et al.
Materials Today. Bio|July 12, 2026
Biomimetic interfacial water-regulated hybrid dual-layer hydrogel for wound healing, anti-adhesion and hemostasis post partial hepatectomyJun Li, Xiang Wu, Yanhua Wan, et al.
International Immunopharmacology|December 19, 2023
SRSF10 facilitates HCC growth and metastasis by suppressing CD8<sup>+</sup>T cell infiltration and targeting SRSF10 enhances anti-PD-L1 therapyXiangyuan Luo, Zerui Zhang, Siwen Li, et al.
Journal for Immunotherapy of Cancer|November 29, 2023
TP53/mTORC1-mediated bidirectional regulation of PD-L1 modulates immune evasion in hepatocellular carcinomaJiongjie Yu, Sunbin Ling, Jiachen Hong, et al.
Signal Transduction and Targeted Therapy|September 19, 2024
The p-MYH9/USP22/HIF-1α axis promotes lenvatinib resistance and cancer stemness in hepatocellular carcinomaQiaonan Shan, Lu Yin, Qifan Zhan, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 21, 2022
E2F7 promotes mammalian target of rapamycin inhibitor resistance in hepatocellular carcinoma after liver transplantationSunbin Ling, Qifan Zhan, Guangjiang Jiang, et al.
Pageof 13